Design of Case Report Forms

Slides:



Advertisements
Similar presentations
Tips to a Successful Monitoring Visit
Advertisements

Document Control DAP Quality Conference May 12, 2008 Debbie Penn.
Review Questions Business 205
A Blueprint For Clinical Research: Standard Operating Procedures
Quality Improvement/ Quality Assurance Amelia Broussard, PhD, RN, MPH Christopher Gibbs, JD, MPH.
Why bother? Trying to do something differently in an academic or NHS setting can sometimes be a frustrating experience.
EDC Metrics: The Full Utilization of EDC Functionality Teresa Ancukiewicz, CCDM Boston Scientific Corporation December 7, 2007.
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
Chapter 11 OFFICE MANAGEMENT.
Using EDC-Rave to Conduct Clinical Trials at Genentech
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Provider Human Rights Coordinator Role Accessing HCSIS to Support Human Rights Committee Reviews September 11, 2013.
Electronic EDI e-EDI. The EDI has been in use since 1999 using a paper-based system and computerized spreadsheets to collect and manage EDI data. Over.
Basics of Good Documentation Document Control Systems
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems.
United Nations Economic Commission for Europe Statistical Division Applying the GSBPM to Business Register Management Steven Vale UNECE
© 2011 Octagon Research Solutions, Inc. All Rights Reserved. The contents of this document are confidential and proprietary to Octagon Research Solutions,
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
CTEP, NCI Adverse Event Reporting Programmatic & Workflow Processes Prepared by: Ann Setser May 24, 2010.
MODULE I Close-Out Visit/Monitoring Reports Jane Fendl April 24, Versions: Final 24-Apr-2010.
MODULE B: Case Report Forms Jane Fendl & Denise Thwing April 7, Version: Final 07-Apr-2010.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
Meet and Confer Rule 26(f) of the Federal Rules of Civil Procedure states that “parties must confer as soon as practicable - and in any event at least.
School of Health Sciences Week 4! AHIMA Practice Brief Fundamentals of Health Information HI 140 Instructor: Alisa Hayes, MSA, RHIA, CCRC.
Investigator’s Meeting
Using EDC-Rave to Conduct Clinical Trials at Genentech Susanne Prokscha Principal CDM PTM Process Analyst February 2012.
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
SCHOOLS FINANCE OFFICERS MEETINGS Records Management, “Paper-Lite” Environments and Procedures when a school closes Elizabeth Barber.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
ADMINISTRATIVE AND CLINICAL HEALTH INFORMATION. Information System - can be define as the use of computer hardware and software to process data into information.
Scientific data storage: How are computers involved in the following?
Research Documentation Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
Responsibilities of Sponsor, Investigator and Monitor
Rare Diseases Clinical Research Network Data Management and Coordinating Center (RDCRN DMCC) Rosalie Holland LDN Investigator Meeting at WORLDSymposium.
Data Management: Source Documents, Case Report Forms and Electronic Data Thomas Salerno, RN BSN MA Senior Team Lead Cardiology Research Jefferson Clinical.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.

Responsibilities of Sponsor, Investigator and Monitor
MAINTAINING THE INVESTIGATOR’S SITE FILE
The Information Professional’s Role in Product Safety
Investigator of Record – Definition
PREPARATION FOR GMP INSPECTION
CLINICAL DATA MANAGEMENT
Component 11/Unit 7 Implementing Clinical Decision Support
Society for Clinical Trials 37th Annual Meeting 2016
Basics of Building and Understanding Data Collection Forms
HOW TO ENTER BASELINE DATA
Clinical Data Management and Case Report Form
Investigator of Record – Definition
Investigator of Record – Definition
Chapter 13 Quality Management
Project Management Process Groups
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Cindy Murray NP Princess Margaret Cancer Centre
Streamlined Data Collection
11 iii. Define management and supervision roles and responsibilities
DESIGN OF CRF CRF.
Discrepancy Management
Code of Ethics for CDM Professionals
(Project) SIGN OFF PROCESS MONTH DAY, YEAR
DESIGN OF CRF CRF.
Getting Grants for Your Small Business
Code of Ethics for CDM Professionals
Marketing Planning Meeting Periodic Marketing Review
Periodic Workflow Review
International Standards and Contemporary Technologies,
Presentation transcript:

Design of Case Report Forms

RDC/RDE (Remote Data Capture, Case Report Form ..CRF Official clinical data-recording document or tool used in a clinical study The Case Report Form is a data-reporting document used in a clinical study. Its purpose is to collect the study data in a specific format that allows for efficient analysis. Data from clinical trials is also collected using computerized Case Report Forms. This is referred to as Remote Site Monitoring (RSM) or Remote Data Entry (RDE). If RSM/RDE is utilized, data is generally entered onto paper workbooks, then input on computer screens which mimic the format of a paper CRF. Data can then be electronically transferred to Pfizer. PAPER RDC/RDE (Remote Data Capture, Remote Data Entry)

Purpose in accordance with the protocol Collects relevant data in a specific format in accordance with the protocol compliance with regulatory requirements Allows for efficient and complete data processing, analysis and reporting Facilitates the exchange of data across projects and organizations esp. through standardization

CRF Relationship to Protocol Protocol determines what data should be collected on the CRF All data must be collected on the CRF if specified in the protocol Data that will not be analyzed should not appear on the CRF

CRF Development Guidelines Collect data with all users in mind Collect data required by the regulatory agencies Collect data outlined in the protocol Be clear and concise with your data questions Avoid duplication Request minimal free text responses

CRF Development Guidelines (con’t) allows for computer summarization Provide units to ensure comparable values Provide instructions to reduce misinterpretations Provide “choices” for each questions allows for computer summarization Use “None” and “Not done”

CRF Development Guidelines (con’t) Collect data in a fashion that: allows for the most efficient computerization similar data to be collected across studies CRF book needs to be finalized and available before an investigator starts enrolling patients into a study Take the time to get it right the first time

Elements of the CRF Three major parts: Header Safety related modules Efficacy related modules Module block of specific questions CRF module(s) make up a single CRF page CRF Book series of CRF pages The term CRF indicates a single CRF page. A series of CRF pages makes up a CRF Book, and one CRF book is completed for each subject enrolled in a study.

Header Information MUST HAVES Key identifying Information Study Number Site/Center Number Subject identification number

Creating Safety Modules Usually come from a standard library Select modules appropriate for your study Keep safety analysis requirements in mind Safety Modules usually include Demographic Adverse Events Vital Signs Medical History/Physical Exam Concomitant Medications Patient Disposition

Efficacy Modules Designed for each therapeutic area based on the protocol Considered to be “unique” modules and can be more difficult to develop Use existing examples from similar protocols where applicable Consider developing a library of efficacy pages Design modules following project standards for data collection

Creating Efficacy Modules Follow general CRF design guidelines Use pages or modules from the therapeutic library Define diagnostics required Include appropriate baseline measurements Repeat same battery of tests Define and identify key efficacy endpoints additional tests for efficacy

Importance of Standard CRFs Prepares the way for data exchange Removes the need for mapping during data exchange Allows for consistent reporting across protocols, across projects Promotes monitoring and investigator staff efficiency Allows merging of data between studies Provides increased efficiency in processing and analysis of of clinical data

CRF Development Process Drafts CRF from protocol CRF Designer CRF Review Meeting Comments back to designer Reviewers CRF Designer The slide shows an overview of the CRF development process. One of the first decision points is to determine which CRA Book format to use. There are two types of formats; one format is designed to retrieve data upon treatment completion (log form), and the other is designed to retrieve data on a visit-by-visit basis. To help with the design, you can access Pfizer’s library of standard CRF pages for collecting safety and demographic data. You can select a template that is appropriate to the needs of the study. Using a template facilitates the assembly of the CRF. With appropriate approval from your group, you may make changes or edits to the safety templates to meet the specific needs of the study. Date requests on the CRF pages which collect efficacy or, for Phase I studies, pharmacokinetic or pharmacodynamic data must parallel the protocol. After drafting any new or unique efficacy or pharmacokinetic/pharmacodynamic pages, it is a good idea to send them to one or two sites that will be conducting the study and ask the site personnel for feedback. Updates CRF to incl. comments Review and Sign off Coordinate printing and distribution Site CRF Book

CRF Development Process Responsibility for CRF design can vary between clinical research organizations (CRA, data manager, specialty role) Include all efficacy and safety parameters specified in the protocol using standards libraries To collect ONLY data required by the protocol Work with protocol grid/visit schedule The CRA is responsible for designing the CRF Book to parallel the efficacy and safety parameters indicated in the protocol.

CRF Development Process Interdisciplinary review is necessary each organization has its own process for review/sign-off Should include relevant members of the project team involved in conduct, analysis and reporting of the trial Begins As soon in the study prep process as possible The CRA is responsible for designing the CRF Book to parallel the efficacy and safety parameters indicated in the protocol.

CRF Development Process Review Team (example) Project Clinician Lead CRA Lead Statistician Lead Programmer Lead Data Manager Others Database Development, Dictionary Coding, Standards CRF development should begin as soon as possible in the study preparation process. However, some CRF pages, such as those relating to efficacy or pharmacokinetics and pharmacodynamics, cannot be finalized until the final protocol has been completed. Draft CRFs are usually reviewed by the clinician, statistician and group leader. There also may be a CRF Review Committee that includes clinical staff as well as Data Management personnel.

CRF Development Process After the CRF book is approved Initiate the process for printing Note: the Protocol must be approved before the CRF book is approved and printed After it is printed Stored according to organizational guidelines Printed and distributed to research sites After the CRF Book has been approved, the process for printing the document is initiated. The completion of this process will vary. After the CRFs have been finalized and printed, a copy of the CRF Book is sent to: Central Files (CRF Librarian), Statistician, Data Coordination Group.

Properly Designed CRF + Components/All of the CRF pages are reusable Saves time Saves money +

Poorly Designed CRF Data not collected Database may require modification Data Entry process impeded Need to edit data Target dates are missed Collected too much data – Wasted resources in collection and processing

The Case Report Form How do we use it? Collect data from the investigational sites Helps project team and study site team Reminder to investigator to perform specific evaluation CRA uses to verify protocol is being followed and compare with source documents Biometrics uses it to build database structures, develop edit checks and programming specs The CRA and Clinician will monitor the data recorded on the CRFs. Although the purpose of the CRF is to collect data, it also helps the study site team and you perform your jobs. The CRF acts as a reminder to the investigator to perform specific evaluations and you can use the CRF to verify that the protocol is being followed (i,e, correct evaluations are being conducted at the appropriate time) and subject safety is being maintained.

The Case Report Form e.g.. APR ...Used for Subject tracking Data analysis and reporting Reports to FDA on subject safety e.g.. APR Promotional materials New Drug Application submissions Support of labeling claims Articles in medical journals CRFs collect all subject data required by the protocol and are used for subject tracking and data analysis. The data that is collected is very important, because it is the basis for making decisions about the drug, its benefits, risks, and potential marketability. Biometricians/Statisticians and Data Management personnel analyze and report the data recorded on the CRFs in the final study reports for the clinical trial. This data is used for reports to the FDA on subject safety (e.g. serious adverse events, annual progress reports, is included in promotional materials and is submitted in NDAs. Additionally, the data from the clinical trial may be used to support labeling claims for the drug or may be published in medical journals. So it is critical that the data be accurate and completes

Electronic CRFs The use of RDC is increasing In general, the concepts for the design of electronic CRFs/RDC screens are the same as covered for paper Electronic CRFs will impact the following: Review of CRF is different (screen review) No need to print and distribute paper